US FDA Commissioner Tries To Allay Concerns About Inspection Postponements

Screenings at ports of entry may be modified, but the drug supply remains safe and secure, Stephen Hahn tells House Committee, arguing that other tools will allow for continued facility policing during the coronavirus outbreak even if the absence of inspections.

US Food and Drug Administration Commissioner Stephen Hahn prepares to testify a House Appropriations Agriculture, Rural Development, FDA and Related Agencies Subcommittee hearing on 11 March 2020.
FDA Commissioner Hahn's first appropriations hearing didn't focus much on the agency's budget request. • Source: Derrick Gingery

More from Manufacturing

More from Compliance